A Validated Clinical Risk Prediction Model for Lung Cancer in Smokers of All Ages and Exposure Types: A HUNT Study

Bossuyt, 2015, STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies, BMJ, 351 Chung, 2008, Prevalence, pathogenesis, and causes of chronic cough, Lancet, 371, 1364, 10.1016/S0140-6736(08)60595-4 De Matteis, 2013, Are women who smoke at higher risk for lung cancer than men who smoke?, Am. J. Epidemiol., 177, 601, 10.1093/aje/kws445 Duan, 2015, Body mass index and risk of lung cancer: systematic review and dose-response meta-analysis, Sci. Rep., 5, 10.1038/srep16938 Harrell, 2001 Heymans, 2007, Variable selection under multiple imputation using the bootstrap in a prognostic study, BMC Med. Res. Methodol., 7, 33, 10.1186/1471-2288-7-33 Hoggart, 2012, A risk model for lung cancer incidence, Cancer Prev. Res. (Phila.), 5, 834, 10.1158/1940-6207.CAPR-11-0237 HUNT Variables Islam, 1994, Declining FEV1 and chronic productive cough in cigarette smokers: a 25-year prospective study of lung cancer incidence in Tecumseh, Michigan, Cancer Epidemiol. Biomarkers Prev., 3, 289 Katki, 2016, Development and validation of risk models to select ever-smokers for CT lung cancer screening, JAMA, 315, 2300, 10.1001/jama.2016.6255 Kessler, 2011, Symptom variability in patients with severe COPD: a pan-European cross-sectional study, Eur. Respir. J., 37, 264, 10.1183/09031936.00051110 Krokstad, 2013, Cohort profile: the HUNT study, Norway, Int. J. Epidemiol., 42, 968, 10.1093/ije/dys095 Li, 2015, Selecting high-risk individuals for lung cancer screening: a prospective evaluation of existing risk models and eligibility criteria in the German EPIC cohort, Cancer Prev. Res. (Phila.), 8, 777, 10.1158/1940-6207.CAPR-14-0424 Marcus, 2015, LLPi: liverpool lung project risk prediction model for lung cancer incidence, Cancer Prev. Res. (Phila.), 8, 570, 10.1158/1940-6207.CAPR-14-0438 Marshall, 2009, Combining estimates of interest in prognostic modelling studies after multiple imputation: current practice and guidelines, BMC Med. Res. Methodol., 9, 57, 10.1186/1471-2288-9-57 Meiners, 2015, Hallmarks of the ageing lung, Eur. Respir. J., 45, 807, 10.1183/09031936.00186914 Moons, 2015, Transparent reporting of a multivariate prediction model for individual prognosis or development I. New guideline for the reporting of studies developing, validating, or updating a multivariable clinical prediction model: the TRIPOD statement, Adv. Anat. Pathol., 22, 303, 10.1097/PAP.0000000000000072 Muller, 2017, Lung cancer risk prediction model incorporating lung function: development and validation in the UK Biobank Prospective Cohort Study, J. Clin. Oncol., 35, 861, 10.1200/JCO.2016.69.2467 Naess, 2008, Cohort profile: cohort of Norway (CONOR), Int. J. Epidemiol., 37, 481, 10.1093/ije/dym217 National Lung Screening Trial Research Team, 2011, Reduced lung-cancer mortality with low-dose computed tomographic screening, N. Engl. J. Med., 365, 395, 10.1056/NEJMoa1102873 Oudkerk, 2017, European position statement on lung cancer screening, Lancet Oncol., 18, e754, 10.1016/S1470-2045(17)30861-6 Patz, 2014, Overdiagnosis in low-dose computed tomography screening for lung cancer, JAMA Intern. Med., 174, 269, 10.1001/jamainternmed.2013.12738 Pepe, 2008, Integrating the predictiveness of a marker with its performance as a classifier, Am. J. Epidemiol., 167, 362, 10.1093/aje/kwm305 Pinsky, 2012, Applying the National Lung Screening Trial eligibility criteria to the US population: what percent of the population and of incident lung cancers would be covered?, J. Med. Screen., 19, 154, 10.1258/jms.2012.012010 Raji, 2012, Predictive accuracy of the Liverpool Lung Project risk model for stratifying patients for computed tomography screening for lung cancer: a case-control and cohort validation study, Ann. Intern. Med., 157, 242, 10.7326/0003-4819-157-4-201208210-00004 Rampinelli, 2017, Exposure to low dose computed tomography for lung cancer screening and risk of cancer: secondary analysis of trial data and risk-benefit analysis, BMJ, 356, j347, 10.1136/bmj.j347 Roe, 2015, Malignant pleural mesothelioma: history, controversy and future of a manmade epidemic, Eur. Respir. Rev., 24, 115, 10.1183/09059180.00007014 Royston, 2013, External validation of a Cox prognostic model: principles and methods, BMC Med. Res. Methodol., 13, 33, 10.1186/1471-2288-13-33 Sogaard, 2004, The Oslo Health Study: the impact of self-selection in a large, population-based survey, Int. J. Equity Health, 3, 3, 10.1186/1475-9276-3-3 Tammemagi, 2013, Selection criteria for lung-cancer screening, N. Engl. J. Med., 368, 728, 10.1056/NEJMoa1211776 Ten Haaf, 2017, Risk prediction models for selection of lung cancer screening candidates: a retrospective validation study, PLoS Med., 14, 10.1371/journal.pmed.1002277 Torre, 2016, Global cancer incidence and mortality rates and trends—an update, Cancer Epidemiol. Biomark. Prev., 25, 16, 10.1158/1055-9965.EPI-15-0578 van Buuren, 2011, mice: Multivariate Imputation by Chained Equations in R., J. Stat. Softw., 45, 1 Vlaanderen, 2014, Effect modification of the association of cumulative exposure and cancer risk by intensity of exposure and time since exposure cessation: a flexible method applied to cigarette smoking and lung cancer in the SYNERGY Study, Am. J. Epidemiol., 179, 290, 10.1093/aje/kwt273 Weber, 2017, Identifying high risk individuals for targeted lung cancer screening: independent validation of the PLCOm2012 risk prediction tool, Int. J. Cancer, 141, 242, 10.1002/ijc.30673 Wu, 2016, Personalized risk assessment in never, light, and heavy smokers in a prospective cohort in Taiwan, Sci. Rep., 6